• Nenhum resultado encontrado

Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.

N/A
N/A
Protected

Academic year: 2016

Share "Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus."

Copied!
14
0
0

Texto

Loading

Referências

Documentos relacionados

4.7 Application to composite volume elements This section presents a few examples of representative volume elements un- der different loading conditions and provides a better insight

Nem as interpolações de raiz ptolomaica, nem a decomposição sub-regional de cada uma das nove unidades asiáticas pré-definidas perturbam o essencial da leitura proposta por

Since intensive glucose control with metformin appears to reduce the risk of diabetes relat- ed end points, especially myocardial infarction and fatal coronary deaths, in

Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system.. M

SHORT-TERM TREATMENT WITH METFORMIN IMPROVES THE CARDIOVASCULAR RISK PROFILE IN FIRST-DEGREE RELATIVES OF SUBJECTS WITH TYPE 2 DIABETES MELLITUS WHO HAVE A METABOLIC SYNDROME

METHODS: A prospective study was performed in 16 uncontrolled patients with diabetes previously treated with dietary intervention. The participants were randomized into metformin

Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.. Diabetes Res

Dual add-on therapy in type 2 diabetes poorly controlled with metfor- min monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus